SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001564590-20-003893
Filing Date
2020-02-07
Accepted
2020-02-07 17:29:54
Documents
14
Period of Report
2020-02-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A mygn-8ka_20200206.htm   iXBRL 8-K/A 47976
2 EX-99.1 mygn-ex991_7.htm EX-99.1 1216244
3 GRAPHIC glx4tm4q05bc000001.jpg GRAPHIC 4230
  Complete submission text file 0001564590-20-003893.txt   1448412

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA mygn-20200206.xsd EX-101.SCH 5960
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mygn-20200206_lab.xml EX-101.LAB 19445
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mygn-20200206_pre.xml EX-101.PRE 11609
12 EXTRACTED XBRL INSTANCE DOCUMENT mygn-8ka_20200206_htm.xml XML 4124
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

IRS No.: 870494517 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K/A | Act: 34 | File No.: 000-26642 | Film No.: 20588550
SIC: 2835 In Vitro & In Vivo Diagnostic Substances